Science

4 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
Ampreloxetine	Royalty Pharma plc (RPRX)

Phase 1(2)

Drug	Company
ORX142	Centessa Pharmaceuticals plc (CNTA)
ORX489	Centessa Pharmaceuticals plc (CNTA)

Unknown(1)

Drug	Company
Next generation bispecific antibody platform	Celldex Therapeutics, Inc. (CLDX)

BioSniper tracks 4 drugs in development for Science across 3 companies.

There are 1 clinical trial targeting Science tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.